Comparison of Reprogramming Methods for Generation of Induced-Oligodendrocyte Precursor Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun-Hye | - |
dc.contributor.author | Park, Chang-Hwan | - |
dc.date.accessioned | 2022-07-13T20:05:54Z | - |
dc.date.available | 2022-07-13T20:05:54Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2017-07 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/152019 | - |
dc.description.abstract | Direct conversion by trans-differentiation is of growing interest in cell therapy for incurable diseases. The efficiency of cell reprogramming and functionality of converted cells are important considerations in cell transplantation therapy. Here, we compared two representative protocols for the generation of Induced-oligodendrocyte progenitor cells (iOPCs) from mouse and rat fibroblasts. Then, we showed that induction of Nkx6.2, Olig2, and Sox10 (NOS) was more effective in mouse fibroblasts and that induction of Olig2, Sox10, and Zfp536 (OSZ) was more effective at reprogramming iOPCs from rat fibroblasts. However, OSZ-iOPCs did not show greater proliferation than NOS-induced cells. Because the efficiency of iOPCs generation appears to differ between cell species depending on transcription factors and culture conditions, it is important to select appropriate methods for efficient reprogramming. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC APPLIED PHARMACOLOGY | - |
dc.title | Comparison of Reprogramming Methods for Generation of Induced-Oligodendrocyte Precursor Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Chang-Hwan | - |
dc.identifier.doi | 10.4062/biomolther.2017.066 | - |
dc.identifier.scopusid | 2-s2.0-85023605751 | - |
dc.identifier.wosid | 000404947800003 | - |
dc.identifier.bibliographicCitation | BIOMOLECULES & THERAPEUTICS, v.25, no.4, pp.362 - 366 | - |
dc.relation.isPartOf | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.title | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.volume | 25 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 362 | - |
dc.citation.endPage | 366 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002233224 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | DIRECT CONVERSION | - |
dc.subject.keywordPlus | DEFINED FACTORS | - |
dc.subject.keywordPlus | FIBROBLASTS | - |
dc.subject.keywordPlus | NEURONS | - |
dc.subject.keywordPlus | MYELIN | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | STRATEGIES | - |
dc.subject.keywordPlus | SUPPORT | - |
dc.subject.keywordAuthor | Direct conversion | - |
dc.subject.keywordAuthor | Oligodendrocyte | - |
dc.subject.keywordAuthor | iOPC | - |
dc.subject.keywordAuthor | Efficiency | - |
dc.identifier.url | https://www.biomolther.org/journal/view.html?volume=25&number=4&spage=362&year=2017 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.